glp-1 anesthesia aGLP-1 receptor agonists & anesthesia: ( practical perioperative approach you can actually use) receptor agonists (e.g., semaglutide, liraglutide, dulaglutide, tirzepatide) are now routine in patients presenting for procedures. For GLP-1 medications are increasingly common,
Description
In the STEP clinical trial program, participants receiving Wegovy lost an average of approximately 15 percent of their body weight over 68 weeks
PlexusDx supports both strategies by helping you understand your personal appetite biology through the Precision Peptide Genetic Test, which maps your genetic predispositions across 14 appetite-control pathways

Gribble, F

Safety outcomes showed no significant difference between SGLT2i and placebo in nasopharyngitis, diarrhea, or hypoglycemia, albeit with a borderline increased risk of urinary tract infections

GLP-1 medicines were first approved for treating Type 2 diabetes, a disease in which the body cant properly use or doesnt make enough insulin to control blood glucose levels, in 2005

Abbreviations ESKD: End-stage kidney disease GLP-1 RA: Glucagon-like peptide-1 receptor agonist HF: Heart failure ICER: Incremental cost-effectiveness ratio MI: Myocardial infarction NDSS: National Diabetes Services Scheme QALY: Quality-adjusted life year SGLT2i: Sodiumglucose co-transporter 2 inhibitor References McGuire DK, Shih WJ, Cosentino F et al (2021) Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis